New scan may spot hidden heart harm in childhood cancer survivors

NCT ID NCT01671696

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 80 childhood cancer survivors who had received high doses of anthracycline chemotherapy. Researchers used cardiac MRI and blood tests to find early signs of heart damage that standard tests might miss. The goal was to see if these advanced methods could detect hidden heart problems before symptoms appear, potentially allowing earlier treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better ways to detect heart damage early in childhood cancer survivors, potentially preventing heart failure.

What could go wrong

This is an observational study, not a treatment trial. The findings may not lead to new therapies, and the small size (80 participants) limits how widely results can be applied.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder childhood malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Connecticut Children's Medical Center

    Hartford, Connecticut, 06106, United States